Business Context and Reporting Period
Company: LMF Acquisition Opportunities Inc. (Note: The input metadata referenced "Seastar Medical," but the filing text identifies the registrant as LMF Acquisition Opportunities Inc., a Special Purpose Acquisition Company or "SPAC").
Reporting Period: Fiscal year ended December 31, 2020 (Inception: October 28, 2020).
Business Overview: The Company is a blank check company incorporated in Delaware for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination with one or more businesses. The Company has not selected any specific target and has not initiated substantive discussions with any target. Management intends to focus on the financial services industry, including FinTech, with target enterprise values of approximately $500 million to $1 billion.
Key Financial Metrics
Revenue: $0 (No operations commenced as of December 31, 2020).
Net Loss: $5,236 for the period from inception through December 31, 2020.
Cash and Liquidity (as of Dec 31, 2020): $38,388.
Assets: Total assets of $269,208, consisting of cash and deferred offering costs ($230,820).
Liabilities: Total liabilities of $249,444, primarily accounts payable ($123,031) and notes payable to related party ($126,413).
Stockholders' Equity: $19,764.
Subsequent Financing (January 2021):
- Initial Public Offering (IPO): Consummated January 28, 2021. Sold 10,350,000 units at $10.00 per unit, generating gross proceeds of $103,500,000.
- Private Placement: Sold 5,738,000 warrants to the Sponsor at $1.00 per warrant, generating gross proceeds of $5,738,000.
- Trust Account: $105,570,000 deposited in a trust account (including deferred underwriting commissions).
- Working Capital: Approximately $974,008 held outside the trust account for working capital purposes.
Material Changes vs. Prior Period
As the Company was formed in October 2020, there is no prior comparable period. The financial statements reflect only organizational activities and costs associated with the preparation for the IPO. The most significant material change occurred subsequent to the reporting period with the consummation of the IPO in January 2021, which transformed the Company from a pre-IPO entity with minimal cash to a public SPAC with over $105 million in trust assets.
Guidance, Outlook, Risks, and Contingencies
Outlook and Strategy: The Company has 18 months from the closing of the IPO (extendable to 21 months) to complete an initial business combination. If no combination is completed, the Company will liquidate and redeem public shares at a pro-rata share of the trust account (initially anticipated at $10.20 per share).
Management Commentary: Management believes the IPO proceeds provide sufficient liquidity to operate for at least 18 months. The Company expects to incur increased expenses related to public company compliance and acquisition search activities.
Risks and Contingencies:
- Going Concern: The independent auditor's report included an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern prior to the IPO, though the IPO proceeds subsequently addressed this.
- Internal Controls: Management identified a material weakness in internal control over financial reporting as of December 31, 2020, due to a lack of segregation of accounting duties.
- Redemption Risk: Public stockholders may redeem shares upon the completion of a business combination, which could reduce the cash available for the transaction.
- Third-Party Claims: The trust account could be subject to claims by creditors, potentially reducing the redemption amount below $10.20 per share, though the Sponsor has agreed to indemnify the trust account against certain claims.
- Extension: The Sponsor must deposit $1,035,000 into the trust account to extend the time to complete a business combination by three months.
Important Facts for Investor Verification
- Identity Discrepancy: Verify the correct registrant name. The filing is for LMF Acquisition Opportunities Inc., not Seastar Medical Holding Corp.
- Trust Account Balance: Confirm the current balance in the trust account ($105,570,000 as of Jan 2021) and any interest earned or withdrawn for taxes.
- Extension Status: Monitor whether the Company has extended the deadline to complete a business combination (initially 18 months from Jan 28, 2021) and if the Sponsor has deposited the required extension funds.
- Target Selection: The Company has not yet identified a target business; verify any subsequent announcements regarding a definitive agreement.
- Redemption Rights: Understand the redemption price (pro-rata share of trust) and the conditions under which public shareholders can redeem their shares.
- Related Party Transactions: Note that the Sponsor holds 20% of the outstanding shares (founder shares) and private placement warrants, and has agreed to vote in favor of any business combination.